EARTHQUAKE AREA COMPANIES BEING SURVEYED BY FDA
This article was originally published in The Gray Sheet
Executive SummaryEARTHQUAKE AREA COMPANIES BEING SURVEYED BY FDA to determine the extent of damage they may have suffered during the Jan. 17 southern California earthquake. The agency's Los Angeles district office is phoning the companies it regulates in the area for reports on the effects of the earthquake. Based on the information provided by firms, FDA will determine if facilities will need to be inspected.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.